Inventor · disambiguated record
Frank Wegmann
Also filed as: WEGMANN FRANK
8 granted patents·1 pending application·19 citations·filing 2016–2021
81Inventor score
Top patents by PatentIndex Score
9 records- 0193US11498944B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·10 cites·28 claims
- 0291US11384122B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·2 cites·30 claims
- 0386US11723970B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0485US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 0578US11229693B2Poxvirus vectors encoding HIV antigens, and methods of use thereofJANSSEN VACCINES & PREVENTION BV·Filed 2018·Granted Jan 25, 2022·1 cites·20 claims
- 0671US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 0770US10973907B2Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigensJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Apr 13, 2021·0 cites·15 claims
- 0849US2022118081A1HIV vaccine regimensJANSSEN VACCINES & PREVENTION BV·Filed 2021·Application pending·0 cites
- 0946US11517618B2Method of inducing an immune response against human immunodeficiency virus by co-localized administration of vaccine componentsJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Dec 6, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Frank Wegmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →